These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 2563272)

  • 21. Generation and characterization of monoclonal antibodies against multiple epitopes on the C-terminal half of envelope gp46 of human T-cell leukemia virus type-I (HTLV-I).
    Tanaka Y; Yasumoto M; Nyunoya H; Ogura T; Kikuchi M; Shimotohno K; Shiraki H; Kuroda N; Shida H; Tozawa H
    Int J Cancer; 1990 Oct; 46(4):675-81. PubMed ID: 1698731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.
    Desgranges C; Souche S; Vernant JC; Smadja D; Vahlne A; Horal P
    AIDS Res Hum Retroviruses; 1994 Feb; 10(2):163-73. PubMed ID: 8198868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The synthetic peptide P-197 inhibits human T-cell leukemia virus type 1 envelope-mediated syncytium formation by a mechanism that is independent of Hsc70.
    Brighty DW; Jassal SR
    J Virol; 2001 Nov; 75(21):10472-8. PubMed ID: 11581416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.
    Chen YM; Zhang XQ; Dahl CE; Samuel KP; Schooley RT; Essex M; Papas TS
    J Immunol; 1991 Oct; 147(7):2368-76. PubMed ID: 1717557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid generation of antibodies against the HTLV-II external envelope protein by growth of mouse plasmacytomas in SCID mice.
    Li QX; Camerini D; Kuritzkes DR; Chen IS
    Virology; 1995 Dec; 214(2):680-4. PubMed ID: 8553576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervicovaginal synthesis of IgG antibodies to the immunodominant 175-199 domain of the surface glycoprotein gp46 of human T-cell leukemia virus type I.
    Bélec L; Georges-Courbot MC; Georges A; Mohamed AS; Londos-Gagliardi D; Hallouin MC; Hocini H; Guillemain B
    J Med Virol; 1996 Sep; 50(1):42-9. PubMed ID: 8890040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of cell-free human T-cell leukemia virus type 1 infection at a postbinding step by the synthetic peptide derived from an ectodomain of the gp21 transmembrane glycoprotein.
    Jinno A; Haraguchi Y; Shiraki H; Hoshino H
    J Virol; 1999 Nov; 73(11):9683-9. PubMed ID: 10516085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunoreactivity of synthetic peptides, corresponding to B-cellular epitopes of human type I T-lymphotrophic virus structural proteins].
    Rasuli AM; Klepikov NN; Andreev SM; Sidorova MV; Vafina MG; Seniuta NB; Pavlish OA; Syrtsev AV; Gurtsevich VE
    Mol Biol (Mosk); 1993; 27(4):880-7. PubMed ID: 8361494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epitope mapping of human monoclonal antibodies recognizing conformational epitopes within HTLV type 1 gp46, employing HTLV type 1/2 envelope chimeras.
    Hadlock KG; Yang Q; Rowe J; Foung SK
    AIDS Res Hum Retroviruses; 2002 Jan; 18(1):57-70. PubMed ID: 11804557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.
    Palker TJ; Riggs ER; Spragion DE; Muir AJ; Scearce RM; Randall RR; McAdams MW; McKnight A; Clapham PR; Weiss RA
    J Virol; 1992 Oct; 66(10):5879-89. PubMed ID: 1326649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heat shock cognate protein 70 is a cell fusion-enhancing factor but not an entry factor for human T-cell lymphotropic virus type I.
    Fang D; Haraguchi Y; Jinno A; Soda Y; Shimizu N; Hoshino H
    Biochem Biophys Res Commun; 1999 Aug; 261(2):357-63. PubMed ID: 10425190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization and epitope mapping of a human monoclonal antibody reactive with the envelope glycoprotein of human immunodeficiency virus.
    Banapour B; Rosenthal K; Rabin L; Sharma V; Young L; Fernandez J; Engleman E; McGrath M; Reyes G; Lifson J
    J Immunol; 1987 Dec; 139(12):4027-33. PubMed ID: 2447158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequence variations in the amino- and carboxy-terminal parts of the surface envelope glycoprotein of HTLV type 1 induce specific neutralizing antibodies.
    Tallet B; Astier-Gin T; Moynet D; Londos-Gagliardi D; Guillemain B
    AIDS Res Hum Retroviruses; 2001 Mar; 17(4):337-48. PubMed ID: 11242520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of antigenic sites of the envelope glycoprotein of the Iranian isolate of human T-cell leukemia virus type 1 with different subtypes of the virus.
    Mohabatkar H; Sadeghi S
    Saudi Med J; 2006 Aug; 27(8):1121-4. PubMed ID: 16883437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-terminal region of human T cell lymphotropic virus type I (HTLVI) p19 core protein is immunogenic in humans and contains an HTLVI-specific epitope.
    Palker TJ; Scearce RM; Copeland TD; Oroszlan S; Haynes BF
    J Immunol; 1986 Apr; 136(7):2393-7. PubMed ID: 2419433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibodies and chemiluminescence immunoassay for detection of the surface protein of human T-cell lymphotropic virus.
    Papsidero LD; Dittmer RP; Vaickus L; Poiesz BJ
    J Clin Microbiol; 1992 Feb; 30(2):351-8. PubMed ID: 1371516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a novel neutralization epitope on envelope gp46 antigen of human T-cell-leukemia virus-type-II (HTLV-II).
    Tanaka Y; Tanaka R; Hoshino H
    Int J Cancer; 1994 Dec; 59(5):655-60. PubMed ID: 7525496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between maternal antibodies to the external envelope glycoprotein and vertical transmission of human T-lymphotropic virus type I. Maternal anti-env antibodies correlate with protection in non-breast-fed children.
    Hino S; Katamine S; Miyamoto T; Doi H; Tsuji Y; Yamabe T; Kaplan JE; Rudolph DL; Lal RB
    J Clin Invest; 1995 Jun; 95(6):2920-5. PubMed ID: 7769134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycosylation-dependent peptide antigenic determinants of env gp46 HTLV-1.
    Kaumaya PT; Conrad SF; DiGeorge AM; Lairmore MD
    Leukemia; 1995 Oct; 9 Suppl 1():S133-8. PubMed ID: 7475306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of a B-cell immunodominant epitope of human T-lymphotropic virus type 1 (HTLV-I) envelope gp46.
    Lairmore MD; Rudolph DL; Roberts BD; Dezzutti CS; Lal RB
    Cancer Lett; 1992 Sep; 66(1):11-20. PubMed ID: 1360328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.